SPONSORED CONTENT

New Thermo Fisher Scientific Manufacturing Facility to produce reliable COVID-19 testing kits in India for India

February 16, 2021 23:30 IST | ANI Press Release
Tennis player James Blake
Thermo Fisher Scientific manufacturing facility

Bengaluru (Karnataka) [India], February 16 (ANI/PNN): A new state-of-the-art Thermo Fisher Scientific manufacturing facility in Bengaluru will produce testing kits and diagnostic solutions that are made in India for use in India.

CoviPathCOVID-19 RT-PCR Kit, which contains the assays and controls for Thermo Fisher's gold standard RT-PCR test intended for the qualitative detection of nucleic acid from SARS-CoV-2 in individuals suspected of COVID-19.

The CoviPathCOVID-19 RT-PCR Kit has been approved under MDR 2017 rules for in vitro diagnostic use by the Indian Council for Medical Research (ICMR) and Drug Control General of India(DCGI)

in all authorized laboratories. Testing with the kit can be done on Applied Biosystems real-time PCR instruments with FAM dye, VIC dye, and JUN dye or any RT-PCR platform with 3 dye channels in molecular biology laboratories approved for testing. Samples are collected from the nasopharyngeal swab, nasopharyngeal aspirate and bronchoalveolar lavage (BAL) specimens.

"Thermo Fisher has been playing a central role in the fight against COVID-19 pandemic. The introduction of this kit and the new facility strengthens our commitment towards the COVID-19 response in India. The new facility is equipped with the capacity to manufacture up to 10 million tests every month. This facility will be instrumental in ensuring access to affordable testing kits while maintaining global quality standards," said Amit Chopra, managing director, India and South Asia, Thermo Fisher Scientific.

The CoviPath COVID-19 RT-PCR Kit is designed to detect viral targets with low mutations and offers more than 99.5% sensitivity and 99.5% specificity. The kit is packaged in a user-friendly and convenient pack size of 200 reactions. The company will make these kits available across the country leveraging its strong distribution network.

"As the country is racing to normalcy, it is imperative to have reliable, affordable and quick-to-deliver testing kits. Thermo Fisher's local production facility will augment the accessibility of testing kits across the country. We are thankful to all our stakeholders and customers for extending their support," said Kapil Sood, senior director, Life Sciences Solutions, Thermo Fisher Scientific, India.

The Applied Biosystems CoviPath COVID-19 RT-PCR Kit is for use in India only. For more product details, kindly visit the website

This story is provided by PNN. ANI will not be responsible in any way for the content of this article. (ANI/PNN)

DISCLAIMER


(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

 

Dear Reader,


Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

New Thermo Fisher Scientific Manufacturing Facility to produce reliable COVID-19 testing kits in India for India

Bengaluru (Karnataka) [India], February 16 (ANI/PNN): A new state-of-the-art Thermo Fisher Scientific manufacturing facility in Bengaluru will produce testing kits and diagnostic solutions that are made in India for use in India.

CoviPathCOVID-19 RT-PCR Kit, which contains the assays and controls for Thermo Fisher's gold standard RT-PCR test intended for the qualitative detection of nucleic acid from SARS-CoV-2 in individuals suspected of COVID-19.

The CoviPathCOVID-19 RT-PCR Kit has been approved under MDR 2017 rules for in vitro diagnostic use by the Indian Council for Medical Research (ICMR) and Drug Control General of India(DCGI)

in all authorized laboratories. Testing with the kit can be done on Applied Biosystems real-time PCR instruments with FAM dye, VIC dye, and JUN dye or any RT-PCR platform with 3 dye channels in molecular biology laboratories approved for testing. Samples are collected from the nasopharyngeal swab, nasopharyngeal aspirate and bronchoalveolar lavage (BAL) specimens.

"Thermo Fisher has been playing a central role in the fight against COVID-19 pandemic. The introduction of this kit and the new facility strengthens our commitment towards the COVID-19 response in India. The new facility is equipped with the capacity to manufacture up to 10 million tests every month. This facility will be instrumental in ensuring access to affordable testing kits while maintaining global quality standards," said Amit Chopra, managing director, India and South Asia, Thermo Fisher Scientific.

The CoviPath COVID-19 RT-PCR Kit is designed to detect viral targets with low mutations and offers more than 99.5% sensitivity and 99.5% specificity. The kit is packaged in a user-friendly and convenient pack size of 200 reactions. The company will make these kits available across the country leveraging its strong distribution network.

"As the country is racing to normalcy, it is imperative to have reliable, affordable and quick-to-deliver testing kits. Thermo Fisher's local production facility will augment the accessibility of testing kits across the country. We are thankful to all our stakeholders and customers for extending their support," said Kapil Sood, senior director, Life Sciences Solutions, Thermo Fisher Scientific, India.

The Applied Biosystems CoviPath COVID-19 RT-PCR Kit is for use in India only. For more product details, kindly visit the website

This story is provided by PNN. ANI will not be responsible in any way for the content of this article. (ANI/PNN)

DISCLAIMER


(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

image
Business Standard
177 22